Voltaren Emulgel 1%
A formulation designed for fast absorption6,7
After topical application, diclofenac penetrates through the skin and into the tissues beneath.8 It is retained in the muscle and other tissues that are often the source of pain.8,9
When it comes to topical NSAIDs, formulation can be more important than concentration.10 The Emulgel formulation possesses the advantages of both gels and emulsions, favouring rapid absorption, ease of application and good acceptability to patients.7,11,12
Voltaren Emulgel 1% penetrates through the skin to a depth of up to 1 cm, enabling targeted action against pain and inflammation.4,5
Effective relief of pain and reduction of inflammation1–3
In a randomised, double-blind, placebo-controlled study of patients with acute neck pain, Voltaren Triple Effect delivered significantly greater reduction in pain-on-movement and pain-at-rest – over three times that of placebo. Additionally, recovery time was about twice as fast as placebo.1*†
*Recovery time was defined as a clinically relevant decrease in pain plus an increase in neck function.†72 patients with acute neck pain received 2 g Voltaren (1%) Emulgel four times daily or placebo for 5 days.
The lowest number-needed-to-treat (NNT) vs other topical NSAIDs in acute musculoskeletal pain3,13
A Cochrane Review comparing topical NSAIDs and placebo showed favourable efficacy for Voltaren Emulgel*† vs other treatments. Of all topical NSAIDs tested for treatment of acute musculoskeletal pain, Voltaren Emulgel had the lowest NNT.3,13‡ with pain relief reported as similar to oral NSAIDs.
This means that for every single patient you treat with Voltaren Emulgel over other topical NSAIDs, you have a better chance of giving them the significant pain relief that helps get them back on their feet and enjoying life again.3
*1% and 2% Voltaren Emulgel formulations included in the review.†For treatment of strains, sprains or sports or overuse-type injuries.‡vs topical ibuprofen, ketoprofen, benzydamine, piroxicam and indomethacin.
Voltaren Emulgel 1% has a reduced systemic side-effect risk14,15
The low systemic absorption of Voltaren Emulgel 1% means that it has a reduced risk of systemic side effects.8,14,15*
*There is an increased risk of mild dermatological side effects (e.g. skin irritation) with topical diclofenac, but this is non-serious and reversible.
First-line medication use
To improve pain, inflammation and recovery after sprains and strains, guidance from the National Institute for Health and Care Excellence (NICE) recommends using topical NSAIDs or paracetamol as initial analgesics for soft-tissue injuries.16
Patients should also be advised not to apply heat to the injury during the first 72 hours.16
Sami wants effective pain relief and fast recovery
Sami balances the demands of his full-time job with taking care of two young children.
He enjoys going to the gym or exercising outdoors and loves nothing more than playing with his children.
The last thing he needs is pain from a sprain or strain affecting his life.
Voltaren Emulgel 1% speeds recovery by relieving pain and reducing inflammation,1 so Sami can get back on with his life.
Recommend Voltaren Emulgel 1% to your patients for reduction of muscle pain and inflammation
100 g Voltaren Emulgel contains 1.16 g diclofenac diethylamine corresponding to 1 g of diclofenac sodium, propylene glycol, isopropyl alcohol, flavoring agents and additional excipients (Propylenglycolum, Isopropanulum, Benzyl benzoat, Aromatica, excipient adunguent, emulgent)17,18
For cutaneous use only. Patients should consult their doctor if the condition does not improve or worsens within 7 days of starting treatment.
The duration of treatment depends on the indication and clinical response. The product should not be used for more than 14 days for soft-tissue injuries or soft-tissue rheumatism, or 21 days for arthritis pain, unless recommended by a doctor.
Adults and adolescents aged 12 and over
Voltaren Emulgel 1% should be applied over the affected area three or four times daily and rubbed gently into the skin. The amount needed depends on the size of the painful area: 2 g to 4 g (cherry to walnut sized) is sufficient to treat an area of about 400–800 cm2. After application, the hands should be washed, unless they are the site being treated.
Do not apply to cuts, open wounds or any other area where the skin is damaged.
After rubbing the gel into the skin, non-occlusive bandages can be used, however without an airtight dressing.
Allow at least four hours between applications of the gel. Do not apply more than four times in any 24-hour period.
The possibility of experiencing systemic adverse events (those associated with the use of systemic forms of diclofenac) should be considered if topical diclofenac is used at a higher dosage or for a longer period of time than recommended. Topical diclofenac should be applied only to intact, non-diseased skin, and not to skin wounds or open injuries. It should not be allowed to come into contact with the eyes or mucous membranes, and should not be ingested. Discontinue the treatment if a skin rash develops after applying the product.
Topical diclofenac can be used with non-occlusive bandages but should not be used with an airtight occlusive dressing.
Contains propylene glycol esters, which may cause mild, localised skin irritation in some people.
Contains benzyl benzoate which may cause mild, localised skin irritation in some people.
- Known hypersensitivity to diclofenac or to any of the excipients
- Patients in whom asthma, angioedema, urticaria, or acute rhinitis are precipitated by acetylsalicylic acid or other NSAIDs
- During the last trimester of pregnancy
For the full description of special warnings and precautions with Voltaren Emulgel 1%, please consult your local Summary of Product Characteristics.
The following convention has been utilised for the classification of undesirable effects: very common (≥ 1/10) common (≥ 1/100 to < 1/10); uncommon (≥ 1/1,000 to < 1/100); rare (≥ 1/10,000 to < 1/1,000); very rare (< 1/10,000):
Infection and infestation
Immune system disorders
Angioedema, hypersensitivity (including urticaria)
Respiratory, thoracic and mediastinal disorders
Skin and subcutaneous tissue disorders Dermatitis (including contact dermatitis), rash, erythema, eczema, pruritus Common Dermatitis bullous Rare Photosensitivity reaction Very rare
For the full list of adverse reactions with Voltaren Emulgel 1%, please consult your local Summary of Product Characteristics.